narrative_review·internal medicine, clinical trial, immunology, research methods, cardiology·PMC10594506
C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians
Diseases · 1 author, 1 centre
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review synthesizes evidence on the biochemistry, pathobiology, and clinical utility of C-Reactive Protein (CRP) as an inflammation biomarker across numerous diseases. It also highlights factors that can lead to false CRP test results and proposes a diagnostic algorithm for clinicians.
Full summary
826 CHARS
It evaluates the current evidence for CRP as a biomarker across a wide spectrum of human diseases, including cardiovascular, respiratory, hepatobiliary, gastrointestinal, renal, and neoplastic conditions, as well as infections and autoimmune diseases. A significant portion discusses molecular diagnostics, detailing preanalytical and analytical errors that can lead to false test results, such as those caused by hemolysis, lipemia, icterus, heterophilic antibodies, and paraproteins. The review concludes that while CRP is a useful marker, its precise predictive or diagnostic role for specific conditions remains unclear in the current literature, and it proposes a novel diagnostic algorithm for clinical assessment. The implications are that clinicians must be aware of potential test interferences to avoid misdiagnosis.